Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the European Commission (EC) has approved ENFLONSIAâ„¢ (clesrovimab) for the prevention of respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results